US Broker Ratings

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 62% Upside Potential

Treace Medical Concepts, Inc. (TMCI) is capturing the attention of investors with its promising growth potential in the healthcare sector, specifically within the medical devices industry. As a key player..

Personalis, Inc. (PSNL) Stock Analysis: Exploring Growth in the Diagnostics & Research Sector

In the rapidly evolving world of healthcare, Personalis, Inc. (NASDAQ: PSNL) stands out as a dynamic player in the diagnostics and research industry. With a market capitalization of $658.02 million,..

Cross Country Healthcare, Inc. (CCRN) Investor Outlook: Navigating a 38.99% Potential Upside Amidst Healthcare Staffing Challenges

Cross Country Healthcare, Inc. (CCRN), a prominent player in the U.S. healthcare staffing industry, presents a unique investment opportunity amidst a challenging operational environment. With its headquarters in Boca Raton,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring an 81.69% Potential Upside in the Biotechnology Sector

Sionna Therapeutics, Inc. (SION) is making waves in the biotechnology industry with its promising pipeline of treatments aimed at combating cystic fibrosis (CF). Headquartered in Waltham, Massachusetts, this clinical-stage biopharmaceutical..

SIGA Technologies Inc. (SIGA) Stock Analysis: Is the High RSI Signaling a Turning Point?

SIGA Technologies Inc. (SIGA), a key player in the healthcare sector’s specialty and generic drug manufacturing industry, presents a fascinating case for investors with its niche focus on the health..

Owens & Minor, Inc. (OMI) Stock Analysis: Assessing Its Healthcare Sector Potential Amidst a 3.15% Upside

Owens & Minor, Inc. (NYSE: OMI) stands as a venerable player in the medical distribution industry, with roots tracing back to 1882. Based in Glen Allen, Virginia, the company has..

Geron Corporation (GERN): Investor Outlook Reveals a 157% Potential Upside and Robust Revenue Growth

In the ever-evolving landscape of biotechnology, Geron Corporation (NASDAQ: GERN) stands out not just for its innovative approaches to oncology, but also for its remarkable potential upside of 157.87% as..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 114.78% Potential Upside in the Healthcare Imaging Market

Butterfly Network, Inc. (NYSE: BFLY) is a compelling player in the healthcare sector, specifically within the medical devices industry. Based in Burlington, Massachusetts, Butterfly Network is revolutionizing the ultrasound imaging..

Immatics N.V. (IMTX)

⚠️ No article content returned.

..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 242.90% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NUVB), a promising player in the biotechnology sector, is capturing investor interest with its compelling potential for upside. With a market capitalization of $711.15 million, this clinical-stage..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Exploring a Potential 244% Upside in Biotech

In the ever-evolving landscape of biotechnology, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out with its innovative pipeline and promising potential for investors. As a clinical-stage biopharmaceutical company headquartered in Cambridge,..

Sana Biotechnology, Inc. (SANA): Investor Outlook and Potential 192% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA) is a promising player in the biotechnology sector, capturing investor attention with its cutting-edge approach to engineered cells as medicines. Headquartered in Seattle, Washington, and..

Sonida Senior Living, Inc. (SNDA) Stock Report: Navigating Growth with a 31% Revenue Surge

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector, specifically within the medical care facilities industry, has been drawing attention with its impressive revenue growth of 31%...

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a Promising 76.79% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a pioneering entity in the healthcare sector focused on molecular diagnostics, continues to capture investor interest with a compelling growth narrative. Headquartered in Friendswood, Texas,..

Avadel Pharmaceuticals plc (AVDL): Investor Outlook Unveils 85% Potential Upside with Strong Buy Ratings

Avadel Pharmaceuticals plc (NASDAQ: AVDL), an innovative biopharmaceutical company headquartered in Dublin, Ireland, is currently capturing investor attention with its promising market prospects. Operating in the healthcare sector, specifically within..

Neuropace, Inc. (NPCE) Investor Outlook: Analyzing the 64.82% Potential Upside in the Medical Device Sector

Neuropace, Inc. (NASDAQ: NPCE) stands out in the healthcare sector, specifically within the medical devices industry, as a company with significant potential for growth and innovation. Headquartered in Mountain View,..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 75% Upside Opportunity

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specializes in medical devices aimed at alleviating pain and enhancing musculoskeletal therapies in the U.S. and beyond. With a..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Is the 311.76% Upside Potential Within Reach?

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a promising player in the biotechnology sector, has emerged as a captivating opportunity for investors looking to dive into the healthcare market. With a..

LENZ Therapeutics (LENZ) Stock Analysis: A 36.80% Upside with Strong Buy Ratings in Biotechnology

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its promising potential for growth. Operating out of Solana Beach, California,..

Taysha Gene Therapies, Inc. (TSHA): Analyst Consensus Projects 240% Upside Potential

Individual investors considering opportunities in the biotechnology sector might find Taysha Gene Therapies, Inc. (NASDAQ: TSHA) worthy of attention. The company, which operates in the healthcare sector with a focus..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds